Eric Van Den Neste
Department of Hematology/Hematological Biology
Cliniques Universitaires UCL Saint-Luc
Brussels
Belgium
Name/email consistency: high
- Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine. Van Den Neste, E., Robin, V., Francart, J., Hagemeijer, A., Stul, M., Vandenberghe, P., Delannoy, A., Sonet, A., Deneys, V., Costantini, S., Ferrant, A., Robert, A., Michaux, L. Leukemia (2007)
- Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review). Van den Neste, E., Cardoen, S., Offner, F., Bontemps, F. Int. J. Oncol. (2005)
- High incidence of complications after 2-chloro-2'-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies. Van Den Neste, E., Michaux, L., Layios, N., Costantini, S., Francart, J., Lambert, C., Sonet, A., André, M., Robert, A., Ferrant, A. Ann. Hematol. (2004)
- Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes. Van Den Neste, E., Smal, C., Cardoen, S., Delacauw, A., Frankard, J., Ferrant, A., Van den Berghe, G., Bontemps, F. Biochem. Pharmacol. (2003)
- Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment. Van Den Neste, E., Delannoy, A., Feremans, W., Ferrant, A., Michaux, L. Leuk. Lymphoma (2001)
- Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2'-deoxyadenosine. Van Den Neste, E., Louviaux, I., Michaux, J.L., Delannoy, A., Michaux, L., Hagemeijer, A., Scheiff, J.M., Bosly, A., Straetmans, N., Ferrant, A. Br. J. Haematol. (1999)
